SCHEMBL29323913

SCHEMBL29323913

COC(=O)c1ncc(C2CN(CC(F)F)CCN2)cc1NC(=O)OC(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.33
ABL1 P00519 1/20 0.30
SRC P12931 1/20 0.30
MC4R P32245 1/20 0.30
MC5R P33032 1/20 0.30
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29320350 0.84 ALDH1A1 (0.36)
SCHEMBL31056846 0.80 PDE4B (0.33) RORCMC4RMC5RPRMT5WDR77
SCHEMBL29323912 0.78 ATR (0.34) RORC
SCHEMBL30109209 0.71 XIAP (0.41)
SCHEMBL30109126 0.71 XIAP (0.41)
SCHEMBL31269556 0.71 XIAP (0.41)
SCHEMBL23500611 0.71 ATR (0.42) RORC
SCHEMBL31056475 0.70 TMEM97 (0.42)
SCHEMBL29320347 0.70 ALDH1A1 (0.38) ABL1SRC
SCHEMBL29323240 0.69 CA12 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed